2013
Lipid Profile, Lipid-lowering Medications, and Intracerebral Hemorrhage After tPA in Get With The Guidelines–Stroke
Messé S, Pervez M, Smith E, Siddique K, Hellkamp A, Saver J, Bhatt D, Fonarow G, Peterson E, Schwamm L. Lipid Profile, Lipid-lowering Medications, and Intracerebral Hemorrhage After tPA in Get With The Guidelines–Stroke. Stroke 2013, 44: 1354-1359. PMID: 23493734, DOI: 10.1161/strokeaha.111.671966.Peer-Reviewed Original ResearchConceptsRisk of sICHSymptomatic intracerebral hemorrhageLipid-lowering medicationsAcute ischemic stroke patientsHigh-density lipoproteinHigher high-density lipoproteinLow-density lipoproteinTissue plasminogen activatorIschemic stroke patientsLower triglyceride levelsDensity lipoproteinTriglyceride levelsGuidelines-StrokeIntracerebral hemorrhageTotal cholesterolStroke patientsPlasminogen activatorUnivariate analysisLipid profileLipid levelsModest risk factorAcute ischemic strokeTotal cholesterol levelsSICH riskIschemic stroke
2007
Serum lipid profile on admission for ischemic stroke
Smith E, Abdullah A, Amirfarzan H, Schwamm L. Serum lipid profile on admission for ischemic stroke. Neurology 2007, 68: 660-665. PMID: 17325272, DOI: 10.1212/01.wnl.0000255941.03761.dc.Peer-Reviewed Original ResearchConceptsLipid-lowering agentsLow-density lipoproteinStroke/TIALDL goalLDL targetsNational Cholesterol Education Program Adult Treatment Panel guidelinesAdult Treatment Panel guidelinesLow-density lipoprotein levelsIschemic stroke/TIACharacteristics of patientsSerum lipid profileATPIII guidelinesCardiovascular eventsIschemic strokeLipoprotein levelsLDL levelsLipid profileMultivariable modelPanel guidelinesLipid measurementsNational guidelinesTherapeutic targetGreater riskPatientsCalendar time